Sign in to confirm you’re not a bot
This helps protect our community. Learn more
Naptumomab – Next generation immunotherapy capable of targeting cold tumors
0Likes
17Views
2020Nov 23
Capital Markets Day 2020, Asher Nathan

Follow along using the transcript.

Active Biotech